Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Toton

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Cancer Drug Targets|November 17, 2017
Autophagy as a Potential Therapeutic Target in Breast Cancer TreatmentNatalia Lisiak, Ewa Toton, Maria Rybczynska
Current Alzheimer Research|April 24, 2020
Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive DisordersMichal Prendecki, Marta Kowalska, Ewa Toton, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 24, 2016
The Synthetic Oleanane Triterpenoid HIMOXOL Induces Autophagy in Breast Cancer Cells via ERK1/2 MAPK Pathway and Beclin-1 Up-regulationNatalia Lisiak, Ewa Toton, Blazej Rubis, et al.
Nutrition and Cancer|February 6, 2016
Zapotin (5,6,2',6'-tetramethoxyflavone) Modulates the Crosstalk Between Autophagy and Apoptosis Pathways in Cancer Cells with Overexpressed Constitutively Active PKCϵEwa Toton, Aleksandra Romaniuk, Jaromir Budzianowski, et al.
BMC Cancer|February 15, 2018
Impact of PKCε downregulation on autophagy in glioblastoma cellsEwa Toton, Aleksandra Romaniuk, Natalia Konieczna, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2017
Telomerase and drug resistance in cancerNatalia Lipinska, Aleksandra Romaniuk, Anna Paszel-Jaworska, et al.
Cellular Signalling|January 27, 2009
Signal transduction of constitutively active protein kinase C epsilonDorota Garczarczyk, Ewa Toton, Verena Biedermann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cellsMalgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
European Journal of Pharmacology|March 3, 2012
The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decreaseEwa Toton, Natalia Lisiak, Blazej Rubis, et al.
Molecular Biology Reports|May 17, 2013
Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent mannerBlazej Rubis, Hanna Holysz, Marta Gladych, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Cancer Drug Targets|November 17, 2017
Autophagy as a Potential Therapeutic Target in Breast Cancer TreatmentNatalia Lisiak, Ewa Toton, Maria Rybczynska
Current Alzheimer Research|April 24, 2020
Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive DisordersMichal Prendecki, Marta Kowalska, Ewa Toton, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 24, 2016
The Synthetic Oleanane Triterpenoid HIMOXOL Induces Autophagy in Breast Cancer Cells via ERK1/2 MAPK Pathway and Beclin-1 Up-regulationNatalia Lisiak, Ewa Toton, Blazej Rubis, et al.
Nutrition and Cancer|February 6, 2016
Zapotin (5,6,2',6'-tetramethoxyflavone) Modulates the Crosstalk Between Autophagy and Apoptosis Pathways in Cancer Cells with Overexpressed Constitutively Active PKCϵEwa Toton, Aleksandra Romaniuk, Jaromir Budzianowski, et al.
BMC Cancer|February 15, 2018
Impact of PKCε downregulation on autophagy in glioblastoma cellsEwa Toton, Aleksandra Romaniuk, Natalia Konieczna, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2017
Telomerase and drug resistance in cancerNatalia Lipinska, Aleksandra Romaniuk, Anna Paszel-Jaworska, et al.
Cellular Signalling|January 27, 2009
Signal transduction of constitutively active protein kinase C epsilonDorota Garczarczyk, Ewa Toton, Verena Biedermann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cellsMalgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
European Journal of Pharmacology|March 3, 2012
The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decreaseEwa Toton, Natalia Lisiak, Blazej Rubis, et al.
Molecular Biology Reports|May 17, 2013
Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent mannerBlazej Rubis, Hanna Holysz, Marta Gladych, et al.
Pageof 2